NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
01/31/2025
Back to search
Official data from USPTO
IMMUNE-ONC THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
01/31/2025
Trademark type
Combined
Nice classes
42
Filing date
05/04/2017
Registration date
05/08/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/31/2025
Last transaction
01/31/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
03/28/2017
First use in commerce
03/28/2017
Drawing code
3
Owner type
03
Owner location
Palo Alto, CA, US
Examiner
PERRY, KIMBERLY B
Current location
Historical data usage
Mark description
The mark consists of the stylized words "IMMUNE-ONC", where "IMMUNE" is in blue and "-ONC" is in orange, above the stylized wording "therapeutics" in orange. Above the wording are four downward curved blue lines above an orange line that is curved upward on both ends.
Holders and representatives
Holders
I. T. (pessoa física)
Representatives
Yi Zhang
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Basic and clinical research in the field of respiratory science and medicine; Development of pharmaceutical preparations and medicines; Research and development of vaccines and medicines; Scientific study and research in the field(s) of medicines; Scientific study and research in the field(s) of healthcare products
Publications
History of USPTO decisions and trademark events.
23 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
01/31/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/30/2025
ES8R
TEAS SECTION 8 RECEIVED
05/07/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/08/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/28/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/28/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/28/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/08/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/20/2018
PUBO
PUBLISHED FOR OPPOSITION
02/20/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/31/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/21/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/21/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/21/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/08/2017
GNRT
NON-FINAL ACTION E-MAILED
08/08/2017
CNRT
NON-FINAL ACTION WRITTEN
08/08/2017
DOCK
ASSIGNED TO EXAMINER
08/02/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/10/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/09/2017
NWAP
NEW APPLICATION ENTERED
05/08/2017
Continuous trademark protection
Get notified about every new filing that threatens IMMUNE-ONC THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.